University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 15 of 17
HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
NCT01023620
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
NCT00986297
Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer
NCT01025882
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
NCT00942708
Effects of Bupivacaine Induced Motor Blockade During the Second Stage of Labor
NCT01621230
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT01302808
High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors
NCT02035852
MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck Cancer
NCT00896350
Resuscitative Endocrinology:Single-dose Clinical Uses for Estrogen-Traumatic Brain Injury
NCT00973674
Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)
NCT00973102
Mechanisms and Treatment of Intradialytic Hypertension
NCT00827775
An Evaluation of Efficacy of the GlideScope Cobalt Video Baton for Intubation on Children Weighing Less Than 10 Kilograms
NCT00935636
Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery
NCT01014897
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
NCT01502787
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
NCT00867126
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
NCT00851877
Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer
NCT01411787
A Trial of Bed Versus Stirrups Delivery in Nulliparous Women for Prevention of Perineal Lacerations
NCT00895973
Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery
NCT01007136
Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis
NCT00855803
Pioglitazone on Pancreatic Steatosis and Bone Health
NCT00855010
Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors
NCT00866086
Primary Care Clinical Practice Elements and Improving Overweight Children's Weight Status
NCT02278705
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
NCT00840463
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT00833261
A Trial of Oral Misoprostol for Labor Augmentation
NCT00906347
Study of N-Acetylcysteine in Acute Liver Failure (ALF)
NCT00896025
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
NCT00667017
Coronary CT Angiography in Acute Chest Pain is a Cost Effective Risk Stratification Strategy
NCT00825435
Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
NCT00744965
The GoodNEWS Lifestyle Enhancement Program
NCT00669630
Plastic Hat Trial to Prevent Hypothermia in Preterm Newborns in the Delivery Room
NCT00904228
Changes in Ectopic Fat Following Surgically Induced Weight Loss
NCT00840307
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
NCT01449955
The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart
NCT01014572
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
NCT00690274
Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
NCT00633061
Using Neuroimaging to Investigate Major Depressive Disorder
NCT00781677
Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
NCT00622466
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
NCT00628550
Physical Therapy Program for Prevention of Shoulder Pain After Device Implant
NCT00680537
Citicoline for Bipolar 1 Disorder and Cocaine Dependence
NCT00619723
Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin
NCT00812071
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
NCT00621946
Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
NCT00645840
Single Incision Laparoscopic Cholecystectomy
NCT00678873
Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
NCT00612313
Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics.
NCT01440634
Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
NCT00616239
Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed
NCT00689754
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.